Becker Capital Management Inc Viatris Inc Transaction History

Becker Capital Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$8.48 - $11.13 $266,950 - $350,372	-31,480 Reduced 73.56%	11,313 $96,000
Q2 2022 Aug 04, 2022	SELL	$9.95 - $12.27 $8.86 Million - $10.9 Million	-890,835 Reduced 95.42%	42,793 $448,000
Q1 2022 May 12, 2022	BUY	$9.81 - $15.4 $737,613 - $1.16 Million	75,190 Added 8.76%	933,628 $10.2 Million
Q4 2021 Feb 08, 2022	BUY	$12.09 - $14.68 $1.96 Million - $2.38 Million	161,825 Added 23.23%	858,438 $11.6 Million
Q3 2021 Oct 14, 2021	BUY	$13.25 - $15.13 $9.23 Million - $10.5 Million	696,613 New	696,613 $9.44 Million
Q1 2021 May 13, 2021	SELL	$13.59 - $18.54 $1.59 Million - $2.17 Million	-117,237 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$14.3 - $18.74 $1.68 Million - $2.2 Million	117,237 New	117,237 $2.2 Million

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Becker Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Becker Capital Management Inc with notifications on news.